General Atlantic led a $320m Series D round in Biofourmis.

General Atlantic, a global growth equity firm, led a $320m Series D round in Biofourmis, a provider of virtual care and digital medicine solutions, with participation from CVS Health. "In recent years, we have seen a significant trend towards virtual at-home care, which has become a critical alternative to in-person care, particularly as digital adoption continues to accelerate. Biofourmis is tapping into this global trend with a new approach to remote care management," Sandeep Naik, General Atlantic Managing Director and Head of India & Southeast Asia. On Aug 10, 2022, Intel Capital joined the round.